Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Using Silica 12CH to Mitigate the Effects and Symptoms of Silicosis in Brazil

NCT06011785 is registered in ClinicalTrials.gov with HOHM Foundation as lead sponsor.

NCT NCT06011785
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06011785 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Using Silica 12CH to Mitigate the Effects and Symptoms of Silicosis in Brazil
Lead sponsor
HOHM Foundation
Phase
Phase 1
Overall status
Unknown status
Start date
March 1, 2024
Completion date
March 1, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

silicosis